- Home
- TSI vs SRTS Comparison
TSI vs SRTS Comparison
Compare TSI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSI | SRTS |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.6M | 67.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | TSI | SRTS |
|---|---|---|
| Price | $4.88 | $4.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 106.8K | 78.3K |
| Earning Date | 01-01-0001 | 02-04-2026 |
| Dividend Yield | ★ 7.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.48 | $3.03 |
| 52 Week High | $4.87 | $9.08 |
Technical Indicators
Market Signals| Indicator | TSI | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 67.90 |
| Support Level | $4.85 | $3.65 |
| Resistance Level | $4.96 | $4.64 |
| Average True Range (ATR) | 0.04 | 0.21 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 22.71 | 77.94 |
Price Performance
Historical ComparisonAbout TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.